Additionally, the obtained results demonstrated ex vivo the presence of type-1 inflammation-related biomarkers such as IP-10, neutrophilic biomarker as ENA-78, or TARC, as well as PARC as an early-type-2 inflammation-related biomarker in the CRS nasal tissues. This evidence concerns the gene CCL18 and congenital rubella syndrome.